Research Supervisor Connect

Preclinical Research in Medicinal Cannabis and Cannabinoid Therapeutics

Summary

Preclinical Research in Medicinal Cannabis and Cannabinoid Therapeutics.

Supervisor

Associate Professor Jonathon Arnold.

Research location

Sydney Medical School - Generic

Program type

PHD

Synopsis

The Lambert Initiative http://sydney.edu.au/science/lambert/ is a research program at the University of Sydney dedicated to exploring the medicinal potential of cannabis and the cannabinoids. We are looking to recruit up to ten new PhD students in 2017 and are offering top-up scholarships of $10,000 p.a. to APA (or equivalent) scholarship recipients who join our team based at the Brain and Mind Centre.

A wide range of chemistry, cellular, preclinical and clinical PhD projects are available for consideration that involve the development and evaluation of cannabis-based treatments for conditions such as of epilepsy, pain, sleep disorders, anxiety disorders, neurodegenerative conditions and cancer. Projects may involve areas such as patient surveys, human psychopharmacology, drug policy and clinical trials. Projects will involve supervision by the Academic and/or Associate Directors of the Lambert Initiative or their specialist collaborators. This is an exciting opportunity for ambitious and enthusiastic graduate students to contribute to a fast-paced program of research at the frontiers of medical science and pharmacology that has strong potential for major societal impact.

Additional information

Jonathon Arnold is an Associate Professor in the Discipline of Pharmacology and Director of the Cannabinoid Research Group. He is Associate Director of Preclinical Research at the Lambert Initiative for Cannabinoid Therapeutics. His current work examines the efficacy of cannabinoids in various cellular and animal models of disease including childhood epilepsy, cancer and PTSD.

Additional supervisors: Professor Iain McGregor, Associate Professor David Allsop, Dr Michael Bowen.

Please note the Research Location is Lambert Initiative For Cannabinoid Therapeutics.

Want to find out more?

Opportunity ID

The opportunity ID for this research opportunity is 2223